The study also showed that vitamin D administered along with IFN-β increased Th2 responses, and decreased Th17 and Th1 cytokines, thus reversing the Th1/th2 bias seen with IFN-β alone in MS. Here, IFNB1 is linked to myeloid sarcoma.